Pages that link to "Q34145444"
Jump to navigation
Jump to search
The following pages link to Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics (Q34145444):
Displaying 50 items.
- Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer (Q24536433) (← links)
- Association of HPC2/ELAC2 genotypes and prostate cancer. (Q24538887) (← links)
- Candidate high myopia loci on chromosomes 18p and 12q do not play a major role in susceptibility to common myopia (Q24800149) (← links)
- The genetics of cancer risk (Q27013910) (← links)
- A candidate prostate cancer susceptibility gene at chromosome 17p (Q28200053) (← links)
- Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci (Q28290530) (← links)
- Prostate cancer susceptibility loci: finding the genes (Q28752597) (← links)
- A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity (Q34020369) (← links)
- Regression models for linkage heterogeneity applied to familial prostate cancer (Q34020676) (← links)
- Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. (Q34020687) (← links)
- Segregation analyses of 1,476 population-based Australian families affected by prostate cancer (Q34020691) (← links)
- Genetics of prostate cancer: too many loci, too few genes (Q34078064) (← links)
- Current status of linkage studies in hereditary prostate cancer (Q34078544) (← links)
- A genomic scan of families with prostate cancer identifies multiple regions of interest (Q34141779) (← links)
- Evidence for a prostate cancer-susceptibility locus on chromosome 20. (Q34141928) (← links)
- Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer (Q34145106) (← links)
- Use of population isolates for mapping complex traits (Q34185425) (← links)
- Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families (Q34308746) (← links)
- Screening for prostate cancer with prostate-specific antigen: beware the biases (Q34453090) (← links)
- Hormones and prostate cancer: current perspectives and future directions (Q34732880) (← links)
- Focus on prostate cancer. (Q34804774) (← links)
- Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants (Q34940745) (← links)
- A tale of two genotypes: consistency between two high-throughput genotyping centers (Q35004089) (← links)
- Genetic susceptibility to prostate cancer: a review. (Q35566211) (← links)
- Inherited predisposition to prostate cancer (Q35585517) (← links)
- Populations at high risk for prostate cancer (Q35609524) (← links)
- Epidemiology of prostate cancer (Q35620871) (← links)
- Emergent trends in the reported incidence of prostate cancer in Nigeria (Q35699402) (← links)
- Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer (Q35764687) (← links)
- Screening for familial and hereditary prostate cancer (Q35861576) (← links)
- Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families (Q36604157) (← links)
- No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed (Q36621593) (← links)
- What should a urologist know about hereditary predisposition to prostate cancer? (Q36682283) (← links)
- Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci (Q36696583) (← links)
- Systematic meta-analyses of gene-specific genetic association studies in prostate cancer (Q37225535) (← links)
- Genetics of Prostate Cancer Risk (Q37812068) (← links)
- Prostate cancer: germline prediction for a commonly variable malignancy. (Q38043095) (← links)
- The complexity of prostate cancer: genomic alterations and heterogeneity. (Q38058243) (← links)
- The genetic epidemiology of prostate cancer and its clinical implications (Q38168060) (← links)
- The clinical genetics of prostate cancer (Q39485394) (← links)
- Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy (Q39650363) (← links)
- Burden of prostate cancer in southwestern Nigeria (Q39932221) (← links)
- Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies (Q42231048) (← links)
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases (Q44204260) (← links)
- Nonparametric linkage analysis using person-specific covariates (Q46113789) (← links)
- Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families (Q47402477) (← links)
- Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics (Q47590869) (← links)
- PCAP is the major known prostate cancer predisposing locus in families from south and west Europe (Q48906885) (← links)
- Heterogeneity in genetic susceptibility to prostate cancer (Q49034145) (← links)
- Segregation Analysis of Prostate Cancer in France: Evidence for Autosomal Dominant Inheritance and Residual Brother-brother Dependence (Q56893640) (← links)